Sign in
4

Changes in Ownership

Tyra Biosciences, Inc. Filed Acc 0001193125-26-129239

Director sold 14,295 shares at $36.97 ($528,506)

  • Director returned 53,172 shares (to the company)
  • Director acquired 53,172 shares (option exercise)
  • Director acquired 14,295 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
KAPLAN GILLA Director 2026-03-25 Option exercise +14,295 $2.25 $32,164 42,526 D: show line 1 in the form
KAPLAN GILLA Director 2026-03-25 Sale −14,295 $36.97 $528,506 28,231 D: show line 2 in the form
KAPLAN GILLA Director 2026-03-26 Option exercise −53,172 $2.25 $119,637 81,403 D: show line 3 in the form
KAPLAN GILLA Director 2026-03-26 Returned to the company −53,172 $37.75 $2,007,153 28,231 D: show line 4 in the form
Open-market sales · 14,295 sh · avg $36.97 · $528,506

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
KAPLAN GILLA Director 2026-03-25 Option exercise · Stock Option (Right to Buy) −14,295 53,172 D: show line 5 in the form
KAPLAN GILLA Director 2026-03-26 Option exercise · Stock Option (Right to Buy) −53,172 0 D: show line 6 in the form
Loading xslF345X06/ownership.xml…